title: Anti-programmed Death Receptor 1 Blockade Induces Clinical Response in a Patient With Metastatic Collecting Duct Carcinoma.
authors.affiliation: Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL. Electronic address: K-rimar@northwestern.edu.
authors.forename: Kalen J
authors.initials: KJ
authors.lastname: Rimar
authors.affiliation: Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL.
authors.forename: Joshua J
authors.initials: JJ
authors.lastname: Meeks
authors.affiliation: Division of Hematology/Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL.
authors.forename: Timothy M
authors.initials: TM
authors.lastname: Kuzel
mesh_terms: D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000378:metabolism; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D008875:Middle Aged; D061026:Programmed Cell Death 1 Receptor / Q000037:antagonists & inhibitors*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*
chemical_list: D061026:Programmed Cell Death 1 Receptor; D047428:Protein Kinase Inhibitors
keywords: Collecting duct carcinoma; Metastatic renal cell carcinoma; Nivolumab; Non–clear cell renal cell carcinoma; PD1 inhibitor